Run both at their standard frequencies
BPC-157, TB-500 which is a fragment of thymosin beta 4, and GHK-Cu copper peptide
How do TB-500 and BPC-157 potentially work together in research models
How to use AOD 9604 AOD 9604 is typically administered via subcutaneous injection, though nasal spray formulations are becoming increasingly available
Understanding the Peptide-Curious Population The individuals exploring BPC-157 supplementation span diverse backgrounds, ages, and health goals, but common themes emerge in the peptide-curious population: Active Adults Experiencing Recovery Challenges: Many BPC-157 users are individuals in their 40s, 50s, and 60s who maintain active lifestyles but notice their bodies no longer recover as quickly from physical stress
--- The Bottom Line The 87.5% responder rate at 12 months is a meaningful data point